ERA Test for IVF: Not Worth the Cost?

A JAMA study involving 750 women found the ERA test, which analyzes uterine lining to time embryo transfers, does not improve live birth rates during IVF. SGF physicians confirmed the test adds unnecessary expense, discomfort, and time without clinical benefits, advising patients to prioritize standard protocols or repeated cycles instead.

---

Key Takeaways

ERA Test Ineffectiveness in IVF Success Rates

Research published in JAMA revealed the endometrial receptivity analysis (ERA) test failed to increase live birth rates in 750 participants compared to standard embryo transfer protocols, contradicting its widespread use in reproductive medicine.

Cost-Effectiveness Concerns for ERAs in Fertility Treatments

The invasive ERA test, costing patients $500–$1,000 with additional clinic fees, provides no measurable clinical benefit. SGF physicians emphasize avoiding unnecessary financial burdens for patients undergoing IVF.

Standard Embryo Transfer Outperforms ERA-Guided Timing

Data from the clinical trial showed no statistical difference in pregnancy outcomes between ERA-guided transfers and chronological transfers based on standard hormonal cycles, validating simpler, non-invasive protocols.

Emotional and Physical Burden of Invasive Fertility Tests

The ERA procedure requires a uterine biopsy, causing discomfort and delays in treatment cycles. Physicians advise patients to focus on evidence-based methods rather than pursuing unproven tests for improved success.

Clinical Trials Clarify Misleading Fertility Tech Claims

This study exemplifies the importance of rigorous clinical validation for emerging fertility technologies. SGF doctors stress that patients should rely on research-backed recommendations to avoid costly, ineffective interventions like ERAs.

---

Source: Read full article